Company logo

ERNA - Eterna Therapeutics Inc.

NASDAQ -> Healthcare -> Biotechnology
San Diego, United States
Type: Equity

ERNA price evolution
ERNA
(in millions $) 30 Jul 2024 1 May 2024 31 Jan 2024 30 Oct 2023
Current assets
Cash $2.59 $5.12 $7.58 $4.55
Short term investments
Net receivables $0.23 $0.35 $0.42 $1.78
Inventory
Total current assets $3.58 $6.16 $9.6 $7.03
Long term investments
Property, plant & equipment $36.64 $37.23 $33.27 $35.03
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $46.49 $49.66 $49.13 $52.25
Current liabilities
Accounts payable $2.19 $2.06 $1.07 $1.46
Deferred revenue
Short long term debt
Total current liabilities $9.6 $7.77 $6.57 $9.63
Long term debt $8.89 $8.01 $6.77 $3.45
Total noncurrent liabilities
Total debt
Total liabilities $55.01 $53.07 $46.9 $48.69
Shareholders' equity
Retained earnings -$199.16 -$193.63 -$186.98 -$180.82
Other shareholder equity
Total shareholder equity
(in millions $) 31 Jan 2024 31 Jan 2023 31 Jan 2022 31 Jan 2021
Current assets
Cash $7.58 $11.45 $16.99
Short term investments
Net receivables $0.42 $0.95 $0.68 $0.12
Inventory
Total current assets $9.6 $13.68 $18.77 $1.72
Long term investments
Property, plant & equipment $33.27 $1.33 $4.24 $0.54
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $49.13 $22.28 $31.53 $3.75
Current liabilities
Accounts payable $1.07 $1.62 $1.76 $0.27
Deferred revenue
Short long term debt
Total current liabilities $6.57 $7.65 $3.68 $2.36
Long term debt $6.77 $1.21 $0.53
Total noncurrent liabilities
Total debt
Total liabilities $46.9 $10.17 $6.02 $2.89
Shareholders' equity
Retained earnings -$186.98 -$165.3 -$140.7 -$135.89
Other shareholder equity $0.25
Total shareholder equity